UCLA Research Program in Pharmaceutical Economics and Policy
Parent: UCLA
eScholarship stats: History by Item for October, 2024 through January, 2025
| Item | Title | Total requests | 2025-01 | 2024-12 | 2024-11 | 2024-10 |
|---|---|---|---|---|---|---|
| 5fg9n284 | Drug Evaluations: Type I vs. Type II Errors | 160 | 44 | 36 | 29 | 51 |
| 7vz4h41m | Differences in Managed Care Drug Formularies: What Can Consumers Learn? | 29 | 14 | 5 | 3 | 7 |
| 85s5w09k | Pharmaceutical Prices and Expenditures | 19 | 5 | 3 | 4 | 7 |
| 46p5p6p4 | Do Managed Care Drug Formularies Signal Health Plan Coverage Generosity | 17 | 8 | 3 | 1 | 5 |
| 0d90459k | The Productivity of Health Care and Pharmaceuticals: An International Comparison | 16 | 4 | 1 | 2 | 9 |
| 5d8758z2 | The Pharmaceutical Research and Development Process, and its Costs | 12 | 4 | 2 | 6 |
Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.